Lesson 4  •  14 Jul 2026
Expanding the Role of Vaginal Estrogen for GSM Symptoms: Urinary, Genital, and Sexual Health
Course overview
This course explores the evolving landscape of menopause medicine, from navigating FDA black box warnings and optimizing hormone therapy to addressing gender disparities, patient education, and evidence-based management of genitourinary syndrome of menopause (GSM). The conversation highlights guideline-driven care, advocacy for vaginal estrogen access, multidisciplinary collaboration, and patient-centered dosing strategies. Join Drs. Suzette Sutherland, Yahir Santiago-Lastra, Kelly Casperson, Rachel Rubin, Melissa Kaufman, and Giulia Ippolito as they share expert perspectives on advancing outcomes for women’s health.
3 hours, 29 lessons
Lessons
Navigating Regulation, Advocacy & Evidence for Hormone Therapy in Menopause Care
Lesson 1
Lesson 2
Advocacy and Evidence: The Path Toward Updated Vaginal Estrogen Labeling
Lesson 3
Evidence Gaps and Gender Disparities in Hormone Therapy and Menopause Management
Lesson 4
Expanding the Role of Vaginal Estrogen for GSM Symptoms: Urinary, Genital, and Sexual Health
Lesson 5
Vaginal Estrogen for Recurrent UTIs: Clinical Evidence, Healthcare Burden, and Advocacy for Access
Lesson 6
Coordinated Advocacy Strategies for Vaginal Estrogen: FDA and Legislative Barriers
Hormone Replacement Therapy in Menopause: Dispelling Myths & Optimizing Outcomes
Lesson 7
HRT Risk Reassessment: Dispelling Myths and Insights from WHI Data
Lesson 8
WHI Study Design Limitations and Media Impact on HRT Risk Interpretation
Lesson 9
Lesson 10
Consequences of Inadequate Education, Misdiagnosis, and Provider Barriers in Menopause Management
Lesson 11
Hormone Therapy in Menopause: Risks of Nonuse and Impact on Longevity
Lesson 12
The Role of Hormones in Preventing Dementia and Cognitive Aging
Lesson 13
Genitourinary Syndrome of Menopause Management: Guidelines, Therapies & Surveillance
Lesson 14
Guideline Creation: Evidence, Expert Opinion, and Clinical Principles in GSM
Lesson 15
Multidisciplinary Referrals and Shared Decision-Making in GSM Guidelines
Lesson 16
Overcoming Barriers: Insurance, Safety, and Efficacy of Long-Term Use of Vaginal Estrogen for GSM
Lesson 17
Clinical Guidelines for GSM: Treatment Selection and Symptom Targeting
Lesson 18
Vaginal Estrogen vs. Alternatives: Evidence for Urinary Symptom Management
Lesson 19
Non-Hormonal GSM Management: Guidelines, Efficacy, and Patient Counseling
Lesson 20
Lesson 21
Endometrial Surveillance and Follow-Up Timelines in Vaginal Estrogen Therapy
Advancing Menopause Medicine: Multidisciplinary Responsibility, Dosing Strategies & Patient-Centered Management
Lesson 22
Specialty Ownership and Training Deficits in Menopause and HRT Management
Lesson 23
Lesson 24
Evolving Best Practices in HRT: Lessons from WHI and Recent Studies
Lesson 25
Practical Approaches to Prescribing Hormone Therapy: Optimizing Dosing and Delivery Methods
Lesson 26
Clinical Considerations for Combining Systemic and Vaginal Estrogen in Menopause Therapy
Lesson 27
Patient-Centered Education and Dosing Strategies in Menopause Hormone Therapy
Lesson 28
Sequencing Estrogen, Progesterone, and Testosterone in Menopause Therapy
Lesson 29
Lab Testing and Patient-Centered Management in Female Hormone Therapy
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.